Fundraising FoxHelius Medical Technologies
NASDAQ: HSDTNewtown, US · Founded 2014 · Delaware corporation · 10 known investors
Find your way into Helius Medical Technologies
A digital asset treasury company that acquires and holds Solana tokens to maximize SOL per share through treasury management and staking activities, while maintaining a secondary focus on neurotechnology for neurological wellness.
Founders & leadership
AF
Antonella Favit-Von PeltExecutive
JS
Jeffrey S. MathiesenExecutive
JS
Jonathan SackierExecutive
AT
Amanda TsengExecutive
PD
Philippe DeschampsExecutive
JL
Joyce LaViscountExecutive
MB
MARCO BANINIExecutive
DC
Dane C. AndreeffPresident and Chief Executive Officer, Director
A"
Agustina "Madelene" Gani TjandrasuwitaChief Operating Officer and Deputy Chief Financial Officer
YD
Yuri DanilovNamed on SEC filing
MT
Mitch TylerNamed on SEC filing
Board
SC
Savio ChiuBoard director
Investors · 10
Animoca BrandsreportedHong Kong · $1.5M – $40M
How we know: press coverage · Not right? Tell us
Arrington CapitalreportedMiami
How we know: press coverage · Not right? Tell us
Aspen Digitalreported
How we know: press coverage · Not right? Tell us
AvenirreportedNew York
How we know: press coverage · Not right? Tell us
Big Brain HoldingsreportedLos Angeles
How we know: press coverage · Not right? Tell us
Columbus CapitalreportedLondon
How we know: the S-1 prospectus · Not right? Tell us
Hashkey CapitalreportedHong Kong · $2M – $43M
How we know: press coverage · Not right? Tell us
Laser DigitalreportedZurich
How we know: press coverage · Not right? Tell us
Pantera CapitalreportedSan Francisco · $5M – $100M
How we know: press coverage · funding news · Not right? Tell us
Summer CapitalreportedCharleston
How we know: press coverage · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$15.4M disclosed across 8 of 9 rounds · 2014–2025
▶$3.7MraisedJan 2025 · 18 investors · Other Health CareRule 506(b)
▶$3.7MraisedJan 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul BuckmanDirector
- Sherrie PerkinsDirector
- Antonella Favit-Von PeltExecutive Officer
- Jeffrey S. MathiesenExecutive Officer, Director
- Blane WalterDirector
- Edward M. StrawDirector
- Dane AndreeffExecutive Officer, Director
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- Sales commissions
- $224K
- Placement agents
- Roth Capital Partners, LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedNov 2020 · 18 investors · Other Health CareRule 506(b)
▶$3.4MraisedNov 2020 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey S. MathiesenDirector
- Mitchell E. TylerDirector
- Edward M. StrawDirector
- Joyce LaViscountExecutive Officer
- Jonathan SackierExecutive Officer
- Dane AndreeffExecutive Officer, Director
- Blane WalterDirector
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- Sales commissions
- $17.5K
- Finders' fees
- $30K
- Placement agents
- H.C. Wainwright & Co., LLC, Joseph Gunnar & Co., LLC
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2020 · 3 investors · Other Health CareRule 506(b)
▶Undisclosed amountofferedMar 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dane AndreeffDirector
- Thomas E. GriffinExecutive Officer
- Joyce LaViscountExecutive Officer
- Edward M. StrawDirector
- Mitchell E. TylerDirector
- Phillippe DeschampsExecutive Officer
- Blane WalterExecutive Officer, Director
- Huaizheng PengExecutive Officer, Director
- Jonathan SackierExecutive Officer
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMay 2016 · 16 investors · Other Health CareRule 506(b)
▶$3MraisedMay 2016 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Philippe DeschampsExecutive Officer, Director
- Blane WalterDirector
- Brian BaptyExecutive Officer
- Joyce LaViscountExecutive Officer
- Huaizheng PengDirector
- Mitch TylerDirector
- Jonathan SackierExecutive Officer
- Savio ChiuDirector
- Edward M. StrawDirector
- Offering amount
- $5.3M
- Amount sold
- $3M
- Sales commissions
- $142.4K
- Placement agents
- Mackie Research Capital Corporation
- First sale
- Apr 2016
- Incorporated
- Corporation, Wyoming, 2014
- Federal exemptions
- 06b
▶$2MraisedOct 2015 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedOct 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mitch TylerDirector
- Savio ChiuDirector
- Philippe DeschampsExecutive Officer, Director
- Jonathan SackierExecutive Officer
- Edward M. StrawDirector
- Joyce LaViscountExecutive Officer, Director
- Yuri DanilovDirector
- Offering amount
- $12.3M
- Amount sold
- $2M
- First sale
- Oct 2015
- Incorporated
- Corporation, Wyoming, 2014
- Federal exemptions
- 06b
▶$270.4KraisedJul 2015 · 4 investors · Other Health CareRule 506(b)
▶$270.4KraisedJul 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mitch TylerDirector
- Philippe DeschampsExecutive Officer, Director
- Amanda TsengExecutive Officer
- Yuri DanilovDirector
- Jonathan SackierExecutive Officer
- Edward M. StrawDirector
- Joyce LaViscountDirector
- Savio ChiuDirector
- Offering amount
- $459K
- Amount sold
- $270.4K
- Finders' fees
- $16.2K
- Placement agents
- March Capital Corp.
- First sale
- Jul 2015
- Incorporated
- Corporation, Wyoming, 2014
- Federal exemptions
- 06b
▶$721.2KraisedJul 2015 · 7 investors · Other Health CareRule 506(b)
▶$721.2KraisedJul 2015 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edward M. StrawDirector
- Savio ChiuDirector
- Amanda TsengExecutive Officer
- Joyce LaViscountDirector
- Philippe DeschampsExecutive Officer, Director
- Mitch TylerDirector
- Jonathan SackierExecutive Officer
- Yuri DanilovDirector
- Offering amount
- $1.2M
- Amount sold
- $721.2K
- Finders' fees
- $40.8K
- Placement agents
- March Capital Corp.
- First sale
- Jun 2015
- Incorporated
- Corporation, Wyoming, 2014
- Federal exemptions
- 06b
▶$1.8MraisedMay 2015 · 12 investors · Other Health CareRule 506(b)
▶$1.8MraisedMay 2015 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SackierExecutive Officer
- Amanda TsengExecutive Officer
- Philippe DeschampsExecutive Officer, Director
- Yuri DanilovDirector
- Joyce LaViscountDirector
- Savio ChiuDirector
- Mitch TylerDirector
- Edward M. StrawDirector
- Offering amount
- $3.1M
- Amount sold
- $1.8M
- Finders' fees
- $84.1K
- Placement agents
- Tobias Tretter, Canaccord Genuity Corp.
- First sale
- Apr 2015
- Incorporated
- Corporation, Wyoming, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Helius Medical Technologies do?
- A digital asset treasury company that acquires and holds Solana tokens to maximize SOL per share through treasury management and staking activities, while maintaining a secondary focus on neurotechnology for neurological wellness.
- Who are Helius Medical Technologies's investors?
- Helius Medical Technologies's investors include Animoca Brands, Arrington Capital, Aspen Digital, Avenir, Big Brain Holdings, Columbus Capital, Hashkey Capital, Laser Digital and 2 more.
- How much funding has Helius Medical Technologies raised?
- Helius Medical Technologies has disclosed $15.4M raised across 8 of its 9 known rounds.
- Where is Helius Medical Technologies headquartered?
- Helius Medical Technologies is headquartered in Newtown, US.